SeaStar Medical Holding Corporation
ICU · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | -0.01 | -0.03 | -0.00 |
| FCF Yield | -220.38% | -107.18% | -14.59% | -3.82% |
| EV / EBITDA | -0.24 | -1.66 | -5.38 | -31.02 |
| Quality | ||||
| ROIC | 1,108.89% | 296.72% | 97.29% | 3,200.02% |
| Gross Margin | 100.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.64 | 0.39 | 0.64 | 1.11 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | – | -100.00% |
| Free Cash Flow Growth | -55.63% | -31.96% | -52.41% | 8.22% |
| Safety | ||||
| Net Debt / EBITDA | 0.05 | -0.80 | -0.76 | -0.48 |
| Interest Coverage | -73.12 | -13.15 | -18.43 | -20.99 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 302.81 | 0.00 | 0.00 | 0.00 |